Metraipolis › archive › dc_19a2c9efec56

Rivaroxaban treatment discontinuation rates in patients with nonvalvular atrial fibrillation in Italian clinical practice: RITMUS-AF — Europe PMC PMID:41678467

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41678467
DOI
10.1371/journal.pone.0341633
License (as archived)
solo-consultazione
Archived
2026-11-05T21:15:23.421Z
SHA-256 of the archived text
f92342ce5d9163d2de4ff60a9fb2fd6e80d25776ad559f3b2f94e30b83898217
Stable URL of this page
https://metraipolis.com/documento/dc_19a2c9efec56

How to cite

Rivaroxaban treatment discontinuation rates in patients with nonvalvular atrial fibrillation in Italian clinical practice: RITMUS-AF — Europe PMC PMID:41678467 — Europe PMC (en), https://europepmc.org/article/MED/41678467 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_19a2c9efec56 (Metraipolis archive dc_19a2c9efec56, sha256 f92342ce5d9163d2de4ff60a9fb2fd6e80d25776ad559f3b2f94e30b83898217)
BibTeX
@misc{dc19a2c9efec56,
  title = {Rivaroxaban treatment discontinuation rates in patients with nonvalvular atrial fibrillation in Italian clinical practice: RITMUS-AF — Europe PMC PMID:41678467},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41678467},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_19a2c9efec56; sha256 f92342ce5d9163d2de4ff60a9fb2fd6e80d25776ad559f3b2f94e30b83898217},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41678467. Agents can read the archived copy with the MCP tool read_document.